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Abstract
Background. Transforming growth factor (TGF)-β 
provides growth control in liver regeneration. We have 
recently demonstrated that TGF-β induced parathyroid 
hormone-related protein (PTHrP) expression and 
secretion, and PTHrP mediated TGF-β-induced apoptosis 
in liver cells. However, whether PTHrP signaling 
pathway is altered during liver regeneration is unknown. 
Therefore we used a murine hepatectomy model in this 
study and tested the hypothesis that both PTHrP and 
TGF-β signaling pathways are upregulated during liver 
regeneration. 
    Methods.  Swiss Webster mice received 70% 
hepatectomy or sham operation and euthanized at different 
time points post-surgery for analyses. Liver regeneration 
was determined by liver/body weight and proliferating 
cell nuclear antigen (PCNA) staining. mRNA levels of 
TGF-β1, TGF-β receptors, PTHrP, and PTHrP receptor 1 
(PTHR1) were measured by real-time quantitative PCR. 
Protein levels of TGF-β1 were measured by ELISA and 
PTHrP and PTHR1 were measured by Western blotting.
      Results.  After 70% hepatectomy, the l iver 
regeneration began at 24 hours and was restored to 82% 
of original liver mass at day 7. TGF-β1 and its receptor 
levels increased at 24 and 48 hours after hepatectomy, 
while PTHrP levels decreased at 12 hours and PTHR1 
levels decreased at 12, 24 and 48 hours after hepatectomy. 
The levels of these molecules returned to similar levels as 
that in sham animals thereafter. 
    Conclusion. We demonstrated that an upregulation 
of the TGF-β and its receptors were associated with a 
down-regulation of PTHrP/PTHR1 expression during 
liver regeneration, which may contribute to hepatocyte 
proliferation and regeneration after hepatectomy. 
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Liver regeneration after hepatic t issue loss is a 
fundamental parameter of liver response. The main causes 
for the loss include liver resection in hepatocellular 
carcinomas and trauma, or liver damage due to viral 
infections, chemicals and alcohol intoxication.(Fausto, 
2004; Fausto & Riehle, 2005) Many growth factors and 
cytokines are involved in orchestrating this regenerative 
process. For instance, tumor necrosis factor (TNF)-α and 
interleukin-6 have been implicated in the initial step of 
rendering hepatocytes in a state of replicate competence. 
As a following step, hepatocyte growth factor (HGF) and 
transforming growth factor (TGF)-α stimulate hepatocyte 
replication. Finally, TGF-β and activin suppress cell 
growth and terminate liver regeneration at a set point. 
(Michalopoulos & DeFrances, 1997; Shimizu et al., 2001) 
Copyright © Canadian Research & Development Center of Sciences and Cultures
2
PTHrP/PTHR1 and TGF-β Levels are InverselyAssociated in Liver Regeneration
TGF-β is a multifunctional protein with a broad 
spectrum of cellular activities ranging from regulation 
of target gene activity to the control of cell growth and 
apoptosis. TGF-β exerts its biological effects through a 
cell surface receptor complex, the TGF-β type I (TβRI) 
and type II receptors (TβRII). Upon ligand binding, TβRII 
phosphorylates TβRI, which subsequently activates the 
canonical pathway by phosphorylating Smad2 and Smad3. 
Phosphorylated Smad2 and Smad3 form a heteromeric 
complex with Smad4. The complex translocates into 
the nucleus, and regulates transcription of target genes, 
including plasminogen activator inhibitor-1, type I 
collagen, the cyclin-dependent-kinase inhibitors p15 and 
p21.(Heldin, Miyazono, & ten Dijke, 1997; Massague, 
1998) TGF-β mRNA presence is low in normal liver cells, 
but increases significantly within a few hours after partial 
hepatectomy.(Braun et al., 1988) Mechanisms underlying 
the early increased TGF-β are still unclear, probably due 
to release of the bound TGF-β from matrix in response to 
perturbations of the matrix. TGF-β in the liver regulates 
parenchymal, inflammatory cells and hepatic stellate 
cells. The early increased TGF-β may be required for 
new matrix synthesis as hepatic histology becomes 
rearranged during and after regeneration.(Michalopoulos 
& DeFrances, 1997) TGF-β also has immunomodulatory 
properties. By in large, TGF-β is considered a specific 
candidate for termination of liver regeneration due 
to its inhibitory effects. TGF-β inhibits hepatocyte 
proliferation and induces apoptosis, thus serves as an 
important negative control limiting the regenerative 
process in response to partial hepatectomy.(Breitkopf, 
Godoy, Ciuclan, Singer, & Dooley, 2006; Karkampouna, 
Ten Dijke, Dooley, & Julio, 2012) Inhibition of TGF-β 
signaling augments liver regeneration.(Liska et al., 2012; 
Zhong et al., 2010)
Parathyroid hormone-related protein (PTHrP) is a 
polyprotein derived from normal and malignant cells. 
The complex growth factor-like properties of PTHrP 
display a variety of effects including the regulation of 
cell differentiation, proliferation and death.(Philbrick 
et al., 1996) In contrast to the situation in humoral 
hypercalcemia of malignancy in which PTHrP plays the 
role of a classical “endocrine” hormone, PTHrP plays 
predominantly paracrine and/or autocrine roles under 
normal circumstances. However, accumulating evidence 
suggests that PTHrP may in fact act more like a cytokine 
than a classic hormone, being widely expressed in normal 
tissues by a variety of cell types, where it has local 
autocrine, paracrine, or intracrine effects.(Philbrick et al., 
1996)
Previous studies demonstrated that TGF-β increases 
PTHrP expression by specifically up-regulating 
transcription from the PTHrP P3 promoter through 
Smad3/Ets1 synergism,(Lindemann, Ballschmieter, 
Nordheim, & Dittmer, 2001) and enhances PTHrP 
secretion through Smad and p38 MAP kinase pathways.
(Kakonen et al., 2002) Neutralization of PTHrP secreted 
by HepG2 liver cells resulted in increased cell growth, 
suggesting that PTHrP can function as an autocrine or 
paracrine growth factor to suppress the growth of the 
liver cells.(Li, Seitz, Selvanayagam, Rajaraman, & 
Cooper, 1996) Recently, we reported that TGF-β induces 
PTHrP expression in hepatocytes in vitro, knockdown 
of PTHrP gene expression or neutralization of secreted 
PTHrP isoforms blocks TGF-β-induced apoptosis. 
Therefore, PTHrP functions as a novel mediator for 
TGF-β-induced apoptosis in liver cells.(Cao et al., 2013) 
Since TGF-β signaling pathway is activated in liver 
regeneration, we attempted to examine in vivo whether 
there is a correlation between levels of TGF-β and 
PTHrP in a hepatectomy model mimicking the process 
of liver regeneration.
METHODS
Animals and experimental design. Swiss Webster 
mice (male, 6-8 weeks) were purchased from Harlan 
(Indianapolis, IN). The mice were randomized to receive 
either 70% hepatectomy or sham operation. (Greene 
& Puder, 2003; Jackson et al., 2008) The mice were 
euthanized over a time course after operation at 12, 24, 
48, 72, and 168 hour (n=5 mice/group/time point), liver 
tissues was harvested, the liver and total body weight were 
recorded, portions of the liver were removed for analysis. 
All animal studies were approved by the Institutional 
Animal Care and Use Committee of The University 
of Texas Medical Branch. Immunohistochemistry 
analysis (IHC) was performed using a monoclonal anti-
proliferating cell nuclear antigen (PCNA) antibody 
(DAKO) as described. (Gao et al., 2014; Gao et al., 
2013; Murray et al., 1999) Real-time quantitative (q)
PCR was performed using Taqman probe sets of mouse 
TGF-β1, TGF-β receptor I (TβRI) and II (TβRII), PTHrP 
and PTHrP receptor 1 (PTHR1) as described.(Cao et 
al., 2007) TGF-β1 protein levels were measured using 
TGF-β1 LINCOplex kit (LINCO Research, St. Charles, 
MO). Western blotting analysis was performed using 
antibodies against PTHrP (Santa Cruz Bio Inc.) and 
PTHR1 (EMD Millipore Calbiochem) as described. (Cao 
et al., 2013) Statistical analysis. Data were expressed as 
mean±SEM. Differences between groups at the indicated 
time points were analyzed by t-test and p<0.05 is 
considered significant. 
RESULTS
Liver regeneration after partial hepatectomy. 
To validate the liver regeneration model following 
hepatectomy, the mice were randomized to receive 
either 70% hepatectomy or sham operation. Following 
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hepatectomy, a gradual increase in remnant liver weight 
was noted in mice. Remnant liver was 2.2% at 12 hours, 
2.7% at 24 hours, 3.7% at 48 hours, 4.2% at 72 hours, and 
4.4% by day 7 of body weight. The liver weight restored 
to 82% compared to sham group by day 7 (Figure 1A). To 
confirm liver regeneration, IHC was performed utilizing 
PCNA antibody, a marker of cell proliferation, on liver 
tissue sections. The PCNA staining increased at 48 hours 
in hepatectomy group, followed by a peak staining at 
72 hours and returned to a similar level as that in sham 
animals by day 7 (Figure 1B). 
Figure 1
Liver regeneration
Swiss Webster mice were randomized to either 70% 
hepatectomy (n=5) or sham operation (n=5). A. Mice 
were sacrificed over a time course after operation, and 
the wet remnant liver weight as a percent of body weight 
was determined as an estimation of liver regeneration. 
Data are expressed as mean±SEM. B. Liver tissue 
sections stained with PCNA were examined at high 
power (200X), and 20 non-overlapped fields were 
evaluated. Nuclear labeling indices for PCNA were 
determined by counting at least 1,000 hepatocyte nuclei. 
Data are expressed as mean±SEM. Arrows point to the 
representative PCNA positive staining. *p<.05 compared 
to sham group. 
Upregulation of TGF-β and its receptor during 
l iver regeneration. TGF-β signaling molecules 
were assessed following hepatectomy using qPCR 
for TGF-β1, TβRI and TβRII mRNA expression in 
liver tissue, and TGF-β1 protein levels in sera. In the 
hepatectomy group, TGF-β1 mRNA expression in 
the liver increased at 24 and 48 hours post-resection 
compared to the sham controls, then returned to a 
similar level as that in sham controls after 72 hours 
(Figure 2A); TGF-β1 protein levels increased in the sera 
at 24 hours post-resection in the hepatectomy group 
(Figure 2B). Furthermore, TβRI mRNA expression 
increased at 24 and 48 hours (Figure 3A); TβRII mRNA 
expression increased at 48 hours post-resection in 
the hepatectomy group compared to the sham group 
(Figure 3B). These results demonstrate components of 
the TGF-β signaling pathway are elevated, suggesting 
that TGF-β signaling pathway is activated during liver 
regeneration.
Figure 2
T G F - β  E x p re s s i o n  I n c re a s e d  D u r i n g  L i v e r 
Regeneration
The mouse liver samples were collected as in Figure 
1. A. qPCR was performed on total RNA isolated from 
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the liver samples to determine TGF-β1 mRNA level. B. 
ELISA was used to quantitate TGF-β1 protein level in the 
mouse sera. Data are expressed as mean±SEM. *p<.05 
compared to sham group.
Figure 3
TGF-β Receptor Expression Increased During Liver 
Regeneration
The mouse liver samples were collected as in Figure 
1. qPCR was performed on RNA isolated from liver to 
determine TβRI (A), and TβRII (B) mRNA levels. Data 
are expressed as mean±SEM. *p<.05 compared to sham 
group.
Downregulation of PTHrP and PTHR1 during 
liver regeneration. PTHrP is induced in rat liver during 
endotoxemia and stimulates the hepatic acute phase 
response, while the PTHR1 mRNA is downregulated 
during this proces. (Funk, Moser, Grunfeld, & Feingold, 
1997). To determine whether PTHrP signaling pathway 
is altered in liver regeneration, PTHrP and PTHR1 
mRNA and protein levels were evaluated in mouse liver 
tissue after hepatectomy. Compared to sham controls, 
PTHrP mRNA levels decreased at 12 hours (Figure 4A), 
and PTHR1 mRNA levels decreased at 12, 24 and 48 
hours (Figure 5A), post-resection in the hepatectomy 
group. Both PTHrP (Figure 4B) and PTHR1 (Figure 
5B) protein levels significantly decreased at 12 hours 
post-resection in the hepatectomy group compared to 
the sham controls. Taken together, these results suggest 
that PTHrP signaling pathway is downregulated during 
hepatic regeneration. 
Figure 4
PTHrP Express ion  Decreased  Dur ing  L iver 
Regeneration
The mouse liver samples were collected as in Figure 
1. A. qPCR was performed on RNA isolated from liver 
to determine PTHrP mRNA levels. B. Western blotting 
analysis was used to determine PTHrP protein levels. 
β-actin served as a protein loading control. PTHrP protein 
signals were quantified and normalized against β-actin. 
Data are expressed as mean±SEM. *p<.05 compared to 
sham group.
The mouse liver samples were collected as in Figure 
1. A. qPCR was performed on RNA isolated from liver 
to determine PTHR1 mRNA levels. B. Western blotting 
analysis was used to determine PTHR1 protein levels. 
β-actin served as a protein loading control. PTHR1 protein 
signals were quantified and normalized against β-actin. 
Data are expressed as mean±SEM. *p<.05 compared to 
sham group.
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Figure 5
PTHR1 Express ion  Decreased  During  Liver 
Regeneration 
The mouse liver samples were collected as in Figure 
1. A. qPCR was performed on RNA isolated from liver 
to determine PTHR1 mRNA levels. B. Western blotting 
analysis was used to determine PTHR1 protein levels. 
β-actin served as a protein loading control. PTHR1 protein 
signals were quantified and normalized against β-actin. 
Data are expressed as mean±SEM. *p<.05 compared to 
sham group.
DISCUSSION
The mechanisms involved in hepatocyte replication and 
liver regeneration following hepatic tissue loss are not 
fully understood. Growth factors and cytokines appear 
to play important roles at various stages of this tightly 
regulated process. The present study demonstrated that the 
expression of TGF-β1 and its receptors increased during 
liver regeneration, suggesting the activation of TGF-β 
signaling pathway. On the other hand, levels of PTHrP 
and its receptor decreased in the mouse liver after partial 
hepatectomy, indicating a down-regulation of PTHrP 
signaling pathway. 
In animal model of liver regeneration, after a 
rapid phase of hepatic growth and restructuring, liver 
regeneration eventually ceases. DNA synthesis is mostly 
completed by 72 hours. TGF-β1, a known inhibitor 
of proliferation in hepatocyte cell lines, is a logical 
candidate to stop the excess replicative and regenerative 
process.(Michalopoulos & DeFrances, 1997) Expression 
of TGF-β1 was shown to be increased during liver 
regeneration induced by a 70% partial hepatectomy 
(Bissell, Wang, Jarnagin, & Roll, 1995; Jakowlew et al., 
1991). After partial hepatectomy, an early peak of TGF-β2 
and -β3 was present in all four cell types, including 
hepatocytes, sinusoidal endothelial cells, Kupffer cells 
(liver macrophages), and lipocytes (Ito or stellate cells), 
followed by a sustained increase in mRNA for TGF-β1, 
-β2, and -β3 primarily in the hepatocyte population (Bissell 
et al., 1995). Our study showed a similar expression 
pattern of TGF-β1 after hepatectomy (Figure 2); however, 
almost at the same time, liver regeneration was occurring 
(Fig. 1). It was observed that hepatocytes isolated from 
regenerating liver from 12 to 48 hours after hepatectomy 
were resistant to TGF-β1 mito-inhibitory effects (Houck & 
Michalopoulos, 1989), which is an important phenomenon 
because it may allow hepatocytes to proliferate even 
though concentrations of TGF-β1 are increasing. 
However, the underlying mechanism responsible for this 
resistance is largely unknown. 
Partial hepatectomy and the hepatotoxin carbon 
tetrachloride (CCl4) are often used experimental models 
for liver regeneration study. In both models, TGF-β 
pathway is activated, and hepatocytes proliferate despite 
the presence of increased TGF-β. Different from partial 
hepatectomy, CC14 model is associated with tissue injury 
and inflammation. Karkampouna’s group demonstrates 
that co-administration of a TβRI inhibitor and CCl4 
promote liver regeneration in mice.(Karkampouna, 
Goumans, Ten Dijke, Dooley, & Kruithof-de Julio, 2015) 
CCl4 specifically damages hepatocytes located around the 
central veins, and the TβRI inhibitor targets hepatocytes 
without affecting other cell types. Thus the findings 
provide important evidence on the specific roles of TGF-β 
in liver regeneration by targeting hepatocytes, and support 
TGF-β as a candidate to terminate liver regeneration. 
Although hepatocytes are parenchymal cells in liver, 
under liver damage or loss, TGF-β is produced by and acts 
on multiple cells for its diverse functions. Its role in other 
cell types deserves further investigation.  
As reported previously, PTHrP mediated TGF-β-
induced growth inhibition in HepG2 liver cells,(Li et al., 
1996) and TGF-β-induced apoptosis in Hep3B and HuH-
7 liver cells.(Cao et al., 2013) The in vivo study of PTHrP 
in mouse liver using endotoxemia model demonstrated 
that PTHrP mRNA expression was induced and PTHR1 
expression was downregulated, providing evidence for 
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the regulated expression of PTHrP in adult liver, and 
suggesting that PTHrP may be one additional member 
of the cytokine/growth factor cascade produced locally 
in liver that can act to stimulate the hepatic acute phase 
response.(Funk et al., 1997) Considering liver as a 
whole organ including multiple cell types, in comparison 
with in vitro studies in hepatocytes, we speculate that 
cell-type specific responses may well exist, what was 
observed is the net outcome from responses of mixed 
cell types.
In the current mouse model, the decreased PTHrP and 
PTHR1 in the earlier stage of regeneration may be due 
to suppression by unidentified mechanisms, rendering 
hepatocytes resistant to TGF-β’s growth inhibitory 
effects. This is in line with the observation that 
hepatocytes isolated from regenerating liver from 12 to 
48 hours after hepatectomy are resistant to TGF-β mito-
inhibitory effects (Houck & Michalopoulos, 1989). Thus, 
hepatocytes proliferate in the presence of increased 
TGF-β. In addition, TGF-β levels are not significantly 
elevated at time points earlier than 24 h, indicating 
regulation of PTHrP/PTH1R independent of TGF-β 
at these earlier stages. We also speculate that in later 
stages, the suppression mechanisms on PTHrP/PTHR1 
diminish. At these later time points, TGF-β levels are 
significantly elevated, with consequent regulation of the 
PTHrP/PTH1R pathway. TGF-β and PTHrP signaling 
pathways therefore reconnect, leading to growth arrest 
of hepatocytes and stop of regeneration. Therefore, our 
current study has advanced our in vitro findings (Cao et 
al., 2013) to an in vivo hepatectomy model and suggests 
a potential link between TGF-β and PTHrP signaling 
pathways that may contribute to hepatocyte proliferation 
and regeneration. 
Opposing effects of TGF-β and PTH have been 
reported in bone remodeling. Phosphorylation of PTH1R 
by TβRII leads to downregulation of PTH signaling, 
while the recruitment of TβRII to PTH1R by PTH 
dampens TGF-β signaling (Qiu et al., 2010). Thus 
TGF-β and PTHrP signaling may work both directions to 
regulate each other’s function in a cell or organ-specific 
context.  
Understanding molecular and cellular mechanisms 
in liver regeneration will facilitate translation of 
experimental data into new treatment strategies, as clinical 
human partial liver transplantation continues to rise. 
Once the isolation and storage of human hepatocytes and 
intrahepatic stem cells are successfully developed, cell 
transplantation might be useful in patients with acute liver 
failure.(Fausto & Riehle, 2005)
As a future scope, the relationship between TGF-β and 
PTHrP can be cross-examined by liver-specific knockout 
of TGF-β or PTHrP signaling molecules in animals for 
functional and signaling analysis. The in vivo approach 
can be coupled with in vitro knockdown in multiple cell 
types for detailed mechanistic studies.   
In conclusion, we have shown that the upregulation 
of TGF-β and the receptor levels are associated with the 
down-regulation of PTHrP/PTHR1 expression during liver 
regeneration. Our data suggest that the down-regulation of 
PTHrP signaling pathway concomitant with the increased 
TGF-β may contribute to hepatocyte proliferation and 
regeneration. Therefore, PTHrP is proposed here as a new 
member of the cytokine/growth factor cascade regulating 
liver regeneration. 
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